Tweet
<img alt="" height="1" width="1" />
Arena Rises as Much as 26% After FDA Letter on Obesity Drug Lorcaserin
Bloomberg
Arena Pharmaceuticals Inc. rose as much as 26 percent after the US Food and Drug Administration said it “regrets” the lack of an animal toxicity expert on an advisory panel that rebuffed the obesity drug ...
Arena shares up ahead of US verdict on diet drugReuters
Arena, shareholders await FDA decision on new diet pillSan Diego Union Tribune
Biotech Stocks Of The day (ARNA, MNKD, VVUS, EXAS)WooEB
Forbes (blog) -FierceBiotech -Wall Street Journal
all 16 news articles »
More...